Abstract

Introduction Parkinson's disease patients carrying a heterozygous mutation in the gene glucocerebrosidase (GBA-PD) show faster motor and cognitive decline than idiopathic Parkinson's disease (iPD) patients, but the mechanisms behind this observation are not well understood. Successful dual tasking (DT) requires a smooth integration of motor and nonmotor operations. This study compared the DT performances between GBA-PD and iPD patients. Methods Eleven GBA-PD patients (p.N370S, p.L444P) and eleven matched iPD patients were included. Clinical characterization included a motor score (Unified PD Rating Scale-III, UPDRS-III) and nonmotor scores (Montreal Cognitive Assessment, MoCA, and Beck's Depression Inventory). Quantitative gait analysis during the single-task (ST) and DT assessments was performed using a wearable sensor unit. These parameters corrected for UPDRS and MoCA were then compared between the groups. Results Under the DT condition “walking while checking boxes,” GBA-PD patients showed slower gait and box-checking speeds than iPD patients. GBA-PD and iPD patients did not show significant differences regarding dual-task costs. Conclusion This pilot study suggests that DT performance with a secondary motor task is worse in GBA-PD than in iPD patients. This finding may be associated with the known enhanced motor and cognitive deficits in GBA-PD compared to iPD and should motivate further studies.

Highlights

  • Parkinson’s disease patients carrying a heterozygous mutation in the gene glucocerebrosidase (GBA-PD) show faster motor and cognitive decline than idiopathic Parkinson’s disease patients, but the mechanisms behind this observation are not well understood

  • During the ST conditions, GBAPD patients walked significantly slower than idiopathic Parkinson’s disease (iPD) patients (0.85 m/s versus 1.07 m/s, p = 0.04)

  • dual tasking (DT) and ST differed between the groups, the Dual-task costs (DTC) of all the speeds were not significantly different between GBA-PD and iPD

Read more

Summary

Introduction

Parkinson’s disease patients carrying a heterozygous mutation in the gene glucocerebrosidase (GBA-PD) show faster motor and cognitive decline than idiopathic Parkinson’s disease (iPD) patients, but the mechanisms behind this observation are not well understood. It has been repeatedly shown that patients with such mutations (GBA-PD patients) present with a different phenotype than idiopathic Parkinson’s disease (iPD) patients They suffer from an earlier age of onset and more rapid disease progression, including motor and nonmotor symptoms, such as cognitive, autonomic, and neuropsychiatric impairment [2,3,4,5,6]. It is not yet clear whether GBA-PD patients differ from iPD patients regarding dual-task (DT) performance. The simultaneous performance of two motor tasks seems to be a valuable fall predictor, fitting well with patients’ balance complaints when, for example, taking a cup out of the cupboard

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call